Add like
Add dislike
Add to saved papers

General Strategy for Controlled Synthesis of Ni x P y /Carbon and Its Evaluation as a Counter Electrode Material in Dye-Sensitized Solar Cells.

Hydrothermal treatment of nickel acetate and phosphoric acid aqueous solution followed with a carbothermal reduction assisted phosphorization process using sucrose as the carbon source for the controlled synthesis of Nix Py /C was successfully realized for the first time. The critical synthesis factors, including reduction temperature, phosphorus/nickel ratio, pH, and sucrose amount were systematically investigated. Remarkably, the carbon serves as a reducer and plays a determinative role in the transformation of Ni2 P2 O7 into Ni2 P/C. The synthesis strategy is divided into four distinguishable stages: (1) hydrothermal preparation of Ni3 (PO4 )2 ·8H2 O precursor for stabilizing P sources; (2) dimerization of Ni3 (PO4 )2 ·8H2 O into more thermal stable Ni2 P2 O7 amorphous phase along with the generation of NiO; (3) carbothermal reduction and phosphidation of NiO into Nix Py (0 ≤ y/x ≤ 0.5); and (4) further phosphidation of mixed-phase Nix Py and carbothermal reduction of Ni2 P2 O7 into single-phase Ni2 P. The resultant Ni2 P, the highly active phase in electrocatalysis, was applied as counter electrode in a dye-sensitized solar cell (DSSC). The DSSC based on Ni2 P with 10.4 wt.% carbon delivers a power conversion efficiency of 9.57%, superior to that of state-of-the-art Pt-based cell (8.12%). The abundant Niδ+ and Pδ- active sites and the metal-like conductivity account for its outstanding catalytic performance.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app